Table 2: Demographic data of patients with pulmonary complications treated with conservative or surgical treatment (42 patients).

 

Patient’s profile

Conservative treatment (N = 32)

Surgical treatment (N = 10)

P-value

Sex

Male, n (%)

Female, n (%)

 

11 (34.38%)

21 (65.63%)

 

2 (20.00%)

8 (80.00%)

 

0.39

Age (years), mean ± SD

55.78 ± 11.04

60.2 ± 7.88

0.25

BMI (kg/m2), mean ± SD

60.92 ± 10.66

59.05 ± 7.97

0.61

Comorbidity, n (%)

Diabetes Mellitus

Hypertension

Dyslipidemia

    

 

6 (18.75%)

12 (37.50%)

5 (15.63%)

 

 

3 (30.00%)

6 (60.00%)

3 (30.00%)

 

 

0.45

0.21

0.31

 

ASA score, n (%)

ASA I

ASA II

ASA III

ASA IV

ASA V

 

8 (25.00%)

20 (62.50%)

4 (12.50%)

0

0

 

0

10 (100.00%)

0

0

0

 

0.07

Preoperative creatinine clearance (mg/kg/min), mean ± SD

58.60 ± 31.33

60.16 ± 58.23

0.91

Previously ipsilateral renal surgery, n (%)

3 (9.38%)

2 (20.00%)

0.36

Laterality, n (%)

Right

Left

 

19 (59.38%)

13 (40.63%)

 

6 (60.00%)

4 (40.00%)

 

0.97

Stone character, n (%)

Staghorn

Multiple

Pelvic/Single calyceal

 

16 (50.00%)

10 (31.25%)

6 (18.75%)

 

4 (40.00%)

6 (60.00%)

0 (0.00%)

 

0.16

Stone diameter (mm), mean ± SD

47.15 ± 21.70

46.9 ± 16.91

0.97

Degree of hydronephrosis, n (%)

No

Mild

Moderate

Severe

 

6 (18.75%)

14 (43.75%)

8 (25.00%)

4 (12.50%)

 

2 (20.00%)

3 (30.00%)

3 (30.00%)

2 (20.00%)

 

0.86

Approach, n (%)

Supracostal

Subcostal

 

18 (56.25%)

14 (43.75%)

 

7 (70.00%)

3 (30.00%)

 

0.44

Operative time (minutes), mean ± SD

97.19 ± 18.71

99.5 ± 16.57

0.73